Patent assignee · US · COMPANY

ALPHAVAX, INC.

20Patents
14Active
20Granted
44Portfolio score

Filing activity: Nov 16, 2001 → Aug 11, 2016 · 8 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US6783939B2 Alphavirus vectors and virosomes with modified HIV genes for use in vaccines Chemistry; Metallurgy 99 Expired
US7442381B2 Alphavirus replicons and helper constructs Chemistry; Metallurgy 57 Expired
US7045335B2 Alphavirus replicon vector systems Chemistry; Metallurgy 42 Expired
US7078218B2 Alphavirus particles and methods for preparation Chemistry; Metallurgy 40 Expired
US7425337B2 Alphavirus replicon vector systems Chemistry; Metallurgy 36 Expired
US7419674B2 Alpha virus-based cytomegalovirus vaccines Chemistry; Metallurgy 32 Expired
US8709441B2 TC-83-derived alphavirus vectors, particles and methods Chemistry; Metallurgy 21 Active
US8460913B2 Promoterless cassettes for expression of alpha virus structural proteins Chemistry; Metallurgy 21 Active
US9441247B2 TC-83-derived alphavirus vectors, particles and methods Chemistry; Metallurgy 15 Active
US7850977B2 Promoterless cassettes for expression of alphavirus structural proteins Chemistry; Metallurgy 13 Active
US8617533B2 Multi-antigenic alphavirus replicon particles and methods Chemistry; Metallurgy 11 Active
US9416370B2 Alphavirus replicon particles matched to protein antigens as immunological adjuvants Emerging Cross-Sectional Technologies 10 Active
US8680258B2 Use of microRNAs to control virus helper nucleic acids Chemistry; Metallurgy 10 Active
US9187729B2 Alphavirus and alphavirus replicon particle formulations and methods Chemistry; Metallurgy 6 Active
US8263092B1 Alphavirus replicon particles as immunological adjuvants Chemistry; Metallurgy 4 Active
US9079943B2 TC-83-derived alphavirus vectors, particles and methods Chemistry; Metallurgy 3 Active
US9597414B2 Use of microRNAs to control virus helper nucleic acids Chemistry; Metallurgy 3 Active
US10111943B2 Alphavirus replicon particles matched to protein antigens as immunological adjuvants Emerging Cross-Sectional Technologies 3 Active
US7910716B2 Nucleic acids encoding modified South African HIV-1 subtype C gag proteins Chemistry; Metallurgy 1 Active
US10570416B2 TC-83-derived alphavirus vectors, particles and methods Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.